Evolution of pathologic T-cell subsets in atopic dermatitis from infancy to adulthood.
The circulating immune phenotype was defined in adults and young children with early atopic dermatitis/AD, but chronologic changes in blood of AD infants and children through adolescence have not been explored. To compare immune activation and cytokine polarization in blood of 0-5y/o (n=39), 6-11y/o (n=26), 12-17y/o (n=21) and ≥18y/o (n=43) patients with AD vs. age-matched controls. Flow cytometry was used to measure interferon-γ, interleukin (IL)-9, IL-13, IL-17, and IL-22 cytokines in CD4+/CD8+ T-cells, with ICOS and HLA-DR defining mid- and long-term T-cell activation, respectively, within skin-homing/CLA+ vs. systemic/CLA- T-cells. Unsupervised clustering differentiated patients based on their blood biomarker frequencies. While CLA+ Th1 frequencies were significantly lower in infants with AD vs. all older patients (P<0.01), CLA+ Th2 T-cells were similarly expanded across all AD age groups compared with controls (P<0.05). After infancy, CLA- Th2 frequencies were increased in AD in all age groups, suggesting systemic immune activation with disease chronicity. IL-22 frequencies serially increased from normal in infants to highly significant levels in adolescents and adults compared to respective controls (P<0.01). Unsupervised clustering aligned the AD profiles along an age-related spectrum from infancy to adulthood (ICOS, IL-22 etc.). The adult AD phenotype is achieved only in adulthood. Unique cytokine signatures characterizing individual pediatric age endotypes may require age-specific therapies. Future longitudinal studies, comparing the profile of cleared vs. persistent pediatric AD, may define age-specific changes that predict AD clearance.